Related Experiment Videos
Heterozygous C2-deficiency and myasthenia gravis
Neurology
|August 1, 1980
Insights
Complement deficiency is newly reported in myasthenia gravis (MG). A patient with typical MG and heterozygous C2 deficiency was studied, including family HLA typing.
Area of Science:
- Immunology
- Neurology
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- Complement system involvement in MG pathogenesis is not fully understood.
Observation:
- A case of a 19-year-old woman with typical myasthenia gravis is presented.
- The patient was found to have heterozygous C2 deficiency.
Findings:
- This is the first reported instance of complement deficiency in a myasthenia gravis patient.
- Human Leukocyte Antigen (HLA) typing was performed on the patient and her family.
Implications:
- This case suggests a potential link between complement C2 deficiency and myasthenia gravis.
- Further research is needed to explore the role of the complement system in MG etiology and progression.
Abstract:
Complement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family.